Urogynaecological research: Current and future developments

International Urogynecology Journal

Volumn 18, Issue 6, 2007, Pages 599-601

  Lose, Gunnar ^a  

^a Glostrup Research Institute   (Denmark)

Author keywords

Devices; Drugtrials; Newprosthesis material; Surgery; Urogynaecological research

Indexed keywords

ARTICLE; DRUG INDUSTRY; DRUG MARKETING; DRUG RESEARCH; HUMAN; MEDICAL ETHICS; MEDICAL LITERATURE; MEDICAL RESEARCH; PRIORITY JOURNAL; PUBLICATION; PUBLISHING; SAFETY; SURGICAL EQUIPMENT; SYSTEMATIC ERROR; TENSION FREE VAGINAL TAPE; UROGENITAL SYSTEM; UROLOGIC SURGERY;

EID: 34249989633     PISSN: 09373462     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00192-007-0318-8     Document Type: Article

References (19)

1. Abrams P, Cardozo L, Khoury S, Wein A (2005) Research methodology, vol 1, Chapter 3. 3rd International Consultation on Incontinence. Health Publication Ltd, Plymouth (Incontinence)
2. Walters MD (2003) The use and misuse of prosthetic materials in reconstructive pelvic surgery: Does the evidence support our surgical practice? Int Urogynecol J 14:365-366
3. Petri E, Kölbl H (2004) Eminence, or rather eloquence, or rather economy-based medicine? Int Urogynecol J 15:147-148
4. McCulloch P, Taylor I, Sasako M, Lovett B, Griffin D (2002) Randomised trials in surgery: Problems and possible solution. BMJ 324:1448-1451
5. Black N (1996) Why we need observational studies to evaluate the effectiveness of health care. BMJ 312:1215-1218
6. Lose G, Ostergard DR (1999) Medical technology assessment and surgery for stress incontinence. Int Urogynecol J 10:351-352
7. Lilford R, Braunholtz D, Harris J, Gill T (2004) Trials in surgery. Br J Surg 91:6-16
8. De Angelis C, Drazen JM, Frizelle FA et al (2004) Clinical trial registration: A statement from the international committee of medical journal editors. N Engl J Med 351:1250-1251
9. Moynihan R (2003) Who pays for the pizza? Redefining the relationships between doctors and drug companies. 1: Entanglement. BMJ 326:1189-1192
10. Korn D, Ehringhaus S (2006) Principles for strengthening the integrity of clinical research. PLOS Clin Trials 1(1):e1, May 2006
11. Lexchin J, Bero LA, Djulbegovic B, Clark O (2003) Pharmaceutical industry sponsorship and research outcome and quality: Systematic review. BMJ 326:1167-1170
12. Gøtzsche PC (2005) Uafhængig klinisk interventionsforskning er meget påkrævet. Ugeskr Læger 167:1491-1494
13. Herbison P, Hay-Smith J, Ellis K, Moor K (2003) Effectiveness of anticholinergic drugs compared with placebo in the treatment of overactive bladder: Systematic review. BMJ 326:841-844
14. Landis JR, Koplan S, Swift S, Versi E (2004) Efficacy of antimuscarinic therapy for overactive bladder with varying degrees of incontinence severity. J Urol 171:752-756
15. Hilton P (2007) Of porcupines and poodles - a joint challenge to industry and the profession. Int Urogynecol J 18(1):3-11
16. Dietz HP (2007) Bias in research and conflict of interest: Why should we care? Int Urogynecol J Pelvic Floor Dysfunct 18(3):241-243. DOI 10.1007/ s00192-006-0236-1
17. Fontanarosa PB, Flanagin A, DeAngelis CD (2005) Reporting conflicts of interest, financial aspects of research, and role of sponsors in funded studies. JAMA 294:110-111
18. Ehringhaus S, Korn D (2006) Principles for protecting integrity in the conduct and reporting of clinical trials. AAMC, 1-7 http://www.aamc.org/ research/clinicaltrialsreporting//clinicaltrialsreporting.pdf March 2006
19. Martinson BC, Anderson MS, de Vries R (2005) Scientists behaving badly. Nature 435(9):737-738